Skip to content

Insider · CIK 0001837830

Ronald W. McClurg

cfoofficer

Files at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). First filing Apr 7, 2025, latest Apr 7, 2025.

In brief

Ronald W. McClurg files SEC Form 4 as CFO at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). Since Apr 7, 2025, Ronald W. McClurg has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Apr 7, 2025.

A track record needs three past buys with six months of prices behind them; Ronald W. McClurg has 0, so none is measured yet.

The newest scored trade: bought $100k of NMTC on Apr 4, 2025, filed Apr 7, 2025, scored 68 (notable).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$100k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NMTC: NEUROONE MEDICAL TECHNOLOGIES Corp

NMTCOct 9, 2026 · close 1.12

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
68Notable
NMTCbuy 2
NEUROONE MEDICAL TECHNOLOGIES Corp
$100k
200,000 shares
+82%0% from low-61% from high

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 17, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+250,000$0.00$0250,000Apr 21, 2025
Apr 4, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
POpen-market purchase
Common Stock
+200,000$0.50$100k444,117Apr 7, 2025
Nov 9, 2023NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+89,283$0.00$089,283Nov 13, 2023

Questions about Ronald W. McClurg

Answered from the filings on this page, as of the latest one.

Is Ronald W. McClurg buying or selling?

Not in the last 12 months. Ronald W. McClurg's latest open-market trade on SEC Form 4 was bought $100k of NMTC on Apr 4, 2025.

How did Ronald W. McClurg's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald W. McClurg has 0.

Where does Ronald W. McClurg file Form 4?

Ronald W. McClurg has filed Form 4 at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ronald W. McClurg: insider trades and track record | InsiderTell